- Home
- MNPR vs HNVR Comparison
MNPR vs HNVR Comparison
Compare MNPR & HNVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- HNVR
- Stock Information
- Founded
- MNPR 2014
- HNVR 2008
- Country
- MNPR United States
- HNVR United States
- Employees
- MNPR N/A
- HNVR N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- HNVR Commercial Banks
- Sector
- MNPR Health Care
- HNVR Finance
- Exchange
- MNPR Nasdaq
- HNVR Nasdaq
- Market Cap
- MNPR 113.5M
- HNVR 129.7M
- IPO Year
- MNPR 2019
- HNVR 2022
- Fundamental
- Price
- MNPR $30.68
- HNVR $25.80
- Analyst Decision
- MNPR Strong Buy
- HNVR Buy
- Analyst Count
- MNPR 3
- HNVR 1
- Target Price
- MNPR $27.33
- HNVR $22.00
- AVG Volume (30 Days)
- MNPR 93.6K
- HNVR 32.5K
- Earning Date
- MNPR 11-08-2024
- HNVR 01-22-2025
- Dividend Yield
- MNPR N/A
- HNVR 1.59%
- EPS Growth
- MNPR N/A
- HNVR N/A
- EPS
- MNPR N/A
- HNVR 1.85
- Revenue
- MNPR N/A
- HNVR $64,015,000.00
- Revenue This Year
- MNPR N/A
- HNVR N/A
- Revenue Next Year
- MNPR N/A
- HNVR $16.84
- P/E Ratio
- MNPR N/A
- HNVR $13.73
- Revenue Growth
- MNPR N/A
- HNVR 6.86
- 52 Week Low
- MNPR $1.55
- HNVR $13.62
- 52 Week High
- MNPR $38.50
- HNVR $27.14
- Technical
- Relative Strength Index (RSI)
- MNPR 76.63
- HNVR 75.74
- Support Level
- MNPR $20.16
- HNVR $23.06
- Resistance Level
- MNPR $25.97
- HNVR $26.11
- Average True Range (ATR)
- MNPR 2.75
- HNVR 1.10
- MACD
- MNPR 0.41
- HNVR -0.11
- Stochastic Oscillator
- MNPR 90.25
- HNVR 67.16
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin for the treatment of soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About HNVR Hanover Bancorp Inc.
Hanover Bancorp Inc is a United States-based banking company. It offers a full range of financial services and employs a complete suite of consumer and commercial banking products and services, including multi-family and commercial mortgages, residential loans, business loans, and lines of credit.